Crohn’s & Colitis Australia welcomes the Federal Government’s announcement that SIMPONI® (golimumab) will be listed on the Pharmaceutical Benefits Scheme (PBS) for people living with moderate to severe ulcerative colitis. “It is vital that people affected by ulcerative colitis have access to affordable treatment options to help them live well. The debilitating symptoms of the … Continue reading CCA welcomes listing of SIMPONI on PBS